Health Coaching for Glaucoma Patients, Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 9
- 试验地点
- 2
- 主要终点
- Glaucoma Medication Adherence
研究概览
简要总结
The study will be conducted to examine the feasibility of using a Health Coach for improving the ophthalmic care of glaucoma patients. Patients taking glaucoma medications will have a coaching intervention and adherence to glaucoma drops will be monitored using a dose-recording device. The dosing data will be analyzed to examine the effect on adherence and qualitative interviews at the conclusion of the study will be used to examine which elements of the coaching experience were most helpful in the glaucoma patient population.
详细描述
Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult whose age is >18 years
- •Diagnosed with glaucoma
- •Patient of Duke Glaucoma Service
- •Prescribed or using topical glaucoma eye medication for at least 6 months
- •Primarily self-administering his or her eye drops
- •English speaking
- •Patient should be able to use the telephone for the coaching intervention,
- •Patient should be available by phone to complete the coaching intervention
- •Patient should be willing and able to use the MEMS (Medication Event Monitoring System) device for recording medication use
- •Patient must be willing and able to come to the Eye Center for an exit interview and to return the MEMS device
- •Patient must be able to give consent
排除标准
- •Patient should be excluded if he or she may need glaucoma surgery or laser during the 6 months of the study period
结局指标
主要结局
Glaucoma Medication Adherence
时间窗: 6 Months
Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage. The average of the participants percentage of time they adhered to using the medication will be reported.
次要结局
未报告次要终点